CareCloud, Inc.: Series A $20.1M

Posted in I - Series A, Q - 3Q11, R - SOUTH EAST, X - TeleMedicine, XX - FL

CareCloud (Miami, FL) a commercial-stage developer provider of cloud-based healthcare management software, closed a $20.1M Series A financing. Participants include Intel Capital and Norwest Venture Partners.

OrthoSensor, Inc.: Series B $21M

Posted in I - Series B, Q - 1Q11, R - SOUTH EAST, X - Device (Monitoring), X - Device (Orthopedic), XX - FL

OrthoSensor (Sunrise, FL) a development-stage medical device company focused on remote monitoring of orthopedic implants, closed a $21M Series B financing. Participants include Ziegler Meditech Equity Partners.

Watermark Medical, Inc.: Series B $6M

Posted in I - Series B, Q - 3Q10, R - SOUTH EAST, X - Device (Sleep Apnea), XX - FL

Watermark Medical (Boca Raton, FL) a commercial-stage medical device company focused on sleep apnea, closed a $6M Series B financing. Participants include Ballast Point Ventures.

Tigris Pharmaceuticals, Inc.: Series C $6.5M

Posted in I - Series C, Q - 3Q10, R - SOUTH EAST, X - Oncology, XX - FL

Tigris Pharmaceuticals (Bonita Springs, FL) a clinical-stage small molecule company focused renal cell, breast and lung cancer, closed a $6.5M Series C financing. Participants include Wexford Spectrum Investors and Sonostar Capital Partners.

Quantum Immunologics, Inc.: Series A $2.2M

Posted in I - Series A, Q - 3Q09, R - SOUTH EAST, X - Oncology, XX - FL

Quantum Immunologics (Tampa, FL) a clinical-stage biopharmaceutical company focused on breast cancer, closed a $2.2M Series A financing. Participants include Mentor Capital.

Applied Genetic Technologies Corp.: Series C $11.8M

Posted in I - Series C, Q - 2Q09, R - SOUTH EAST, X - Emphysema, X - Opthalmology, XX - FL

Applied Genetic Technlogies (Alachua, Fl) a clinical-stage biopharmaceutical company developing gene therapy treatments for Alpha-1 Antitrypsin Deficiency and Leber’s Congenital Amaurosis, closed a $11.8M Series C financing. Participants include InterWest, Intersouth Partners and MedImmune Ventures.

to top of page...